市場調査レポート

商品コード

爪真菌症治療の世界市場、2024年～2028年

Global Onychomycosis Treatment Market 2024-2028

出版日: 2024年08月14日
発行: TechNavio
ページ情報: 英文 168 Pages
納期: 即納可能

カスタマイズ可能

価格

PDF (Single User License)

USD 2,500 360,150円

レポートPDFをご購入者の1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 4,000 576,240円

レポートPDFを同一組織内のすべての方にて共有ご使用頂けるライセンスです。ご利用人数に制限はありません。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は制限なく何回でも可能ではありますが、印刷物のご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

爪真菌症治療市場は2023-2028年に17億7,200万米ドル、予測期間中のCAGRは7.03%で成長すると予測されます。

当レポートでは、爪真菌症治療市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、爪真菌症の有病率の増加、爪真菌症治療の認知度の向上、高齢化人口の増加によって牽引されています。

市場範囲
基準年	2024
終了年	2028
予測期間	2024-2028
成長モメンタム	加速
前年比2024年	6.57%
CAGR	7.03%
増分額	17億7,200万米ドル

本調査では、今後数年間の爪真菌症治療市場成長を牽引する主な要因の1つとして、爪真菌症の外用治療に対する需要の増加を挙げています。また、爪真菌症治療における技術の進歩や、爪真菌症治療のための併用療法の採用が増加していることも、市場の大きな需要につながると思われます。

地域別セグメンテーション
地域別比較
北米：市場規模と予測 2023-2028
欧州：市場規模と予測 2023-2028
アジア：市場規模と予測 2023-2028
世界のその他の地域：市場規模と予測 2023-2028
米国：市場規模と予測 2023-2028
ドイツ：市場規模と予測 2023-2028
英国：市場規模と予測 2023-2028
中国：市場規模と予測 2023-2028
日本：市場規模と予測 2023-2028
市場機会：地域情勢別

第10章促進要因・課題・機会・抑制要因

市場促進要因
市場の課題
促進要因と課題の影響
市場の機会・抑制要因

第11章競合情勢

概要
競合情勢
混乱の状況
業界のリスク

第12章競合分析

企業プロファイル
企業の市場ポジショニング
Almirall SA
Astellas Pharma Inc.
Bausch Health Companies Inc.
Bayer AG
Cipla Inc.
Fotona d.o.o
Galderma SA
GlaxoSmithKline Plc
Kaken Pharmaceutical Co. Ltd.
Medimetriks Pharmaceuticals Inc.
Moberg Pharma AB
Novartis AG
Pfizer Inc.
Sanofi SA
The OTClab B.V.

第13章付録

図表

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Parent Market
Exhibits11: Data Table on - Parent Market
Exhibits12: Market characteristics analysis
Exhibits13: Value Chain Analysis
Exhibits14: Offerings of companies included in the market definition
Exhibits15: Market segments
Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits20: Historic Market Size - Data Table on Global Onychomycosis Treatment Market 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits25: Five forces analysis - Comparison between 2023 and 2028
Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits31: Chart on Market condition - Five forces 2023 and 2028
Exhibits32: Chart on Type - Market share 2023-2028 (%)
Exhibits33: Data Table on Type - Market share 2023-2028 (%)
Exhibits34: Chart on Comparison by Type
Exhibits35: Data Table on Comparison by Type
Exhibits36: Chart on Pharmacological - Market size and forecast 2023-2028 ($ million)
Exhibits37: Data Table on Pharmacological - Market size and forecast 2023-2028 ($ million)
Exhibits38: Chart on Pharmacological - Year-over-year growth 2023-2028 (%)
Exhibits39: Data Table on Pharmacological - Year-over-year growth 2023-2028 (%)
Exhibits40: Chart on Non-pharmacological - Market size and forecast 2023-2028 ($ million)
Exhibits41: Data Table on Non-pharmacological - Market size and forecast 2023-2028 ($ million)
Exhibits42: Chart on Non-pharmacological - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on Non-pharmacological - Year-over-year growth 2023-2028 (%)
Exhibits44: Market opportunity by Type ($ million)
Exhibits45: Data Table on Market opportunity by Type ($ million)
Exhibits46: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits47: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits48: Chart on Comparison by Distribution Channel
Exhibits49: Data Table on Comparison by Distribution Channel
Exhibits50: Chart on Offline - Market size and forecast 2023-2028 ($ million)
Exhibits51: Data Table on Offline - Market size and forecast 2023-2028 ($ million)
Exhibits52: Chart on Offline - Year-over-year growth 2023-2028 (%)
Exhibits53: Data Table on Offline - Year-over-year growth 2023-2028 (%)
Exhibits54: Chart on Online - Market size and forecast 2023-2028 ($ million)
Exhibits55: Data Table on Online - Market size and forecast 2023-2028 ($ million)
Exhibits56: Chart on Online - Year-over-year growth 2023-2028 (%)
Exhibits57: Data Table on Online - Year-over-year growth 2023-2028 (%)
Exhibits58: Market opportunity by Distribution Channel ($ million)
Exhibits59: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits61: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits62: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits63: Chart on Geographic comparison
Exhibits64: Data Table on Geographic comparison
Exhibits65: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits66: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits67: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits68: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits69: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits70: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits71: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits72: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits73: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits86: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits87: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits90: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits91: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits94: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits95: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits98: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits99: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits101: Market opportunity By Geographical Landscape ($ million)
Exhibits102: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits103: Impact of drivers and challenges in 2023 and 2028
Exhibits104: Overview on criticality of inputs and factors of differentiation
Exhibits105: Overview on factors of disruption
Exhibits106: Impact of key risks on business
Exhibits107: Companies covered
Exhibits108: Matrix on companies position and classification
Exhibits109: Almirall SA - Overview
Exhibits110: Almirall SA - Product / Service
Exhibits111: Almirall SA - Key news
Exhibits112: Almirall SA - Key offerings
Exhibits113: Astellas Pharma Inc. - Overview
Exhibits114: Astellas Pharma Inc. - Product / Service
Exhibits115: Astellas Pharma Inc. - Key news
Exhibits116: Astellas Pharma Inc. - Key offerings
Exhibits117: Bausch Health Companies Inc. - Overview
Exhibits118: Bausch Health Companies Inc. - Business segments
Exhibits119: Bausch Health Companies Inc. - Key news
Exhibits120: Bausch Health Companies Inc. - Key offerings
Exhibits121: Bausch Health Companies Inc. - Segment focus
Exhibits122: Bayer AG - Overview
Exhibits123: Bayer AG - Business segments
Exhibits124: Bayer AG - Key news
Exhibits125: Bayer AG - Key offerings
Exhibits126: Bayer AG - Segment focus
Exhibits127: Cipla Inc. - Overview
Exhibits128: Cipla Inc. - Business segments
Exhibits129: Cipla Inc. - Key news
Exhibits130: Cipla Inc. - Key offerings
Exhibits131: Cipla Inc. - Segment focus
Exhibits132: Fotona d.o.o - Overview
Exhibits133: Fotona d.o.o - Product / Service
Exhibits134: Fotona d.o.o - Key offerings
Exhibits135: Galderma SA - Overview
Exhibits136: Galderma SA - Product / Service
Exhibits137: Galderma SA - Key offerings
Exhibits138: GlaxoSmithKline Plc - Overview
Exhibits139: GlaxoSmithKline Plc - Business segments
Exhibits140: GlaxoSmithKline Plc - Key news
Exhibits141: GlaxoSmithKline Plc - Key offerings
Exhibits142: GlaxoSmithKline Plc - Segment focus
Exhibits143: Kaken Pharmaceutical Co. Ltd. - Overview
Exhibits144: Kaken Pharmaceutical Co. Ltd. - Product / Service
Exhibits145: Kaken Pharmaceutical Co. Ltd. - Key offerings
Exhibits146: Medimetriks Pharmaceuticals Inc. - Overview
Exhibits147: Medimetriks Pharmaceuticals Inc. - Product / Service
Exhibits148: Medimetriks Pharmaceuticals Inc. - Key offerings
Exhibits149: Moberg Pharma AB - Overview
Exhibits150: Moberg Pharma AB - Product / Service
Exhibits151: Moberg Pharma AB - Key offerings
Exhibits152: Novartis AG - Overview
Exhibits153: Novartis AG - Business segments
Exhibits154: Novartis AG - Key news
Exhibits155: Novartis AG - Key offerings
Exhibits156: Novartis AG - Segment focus
Exhibits157: Pfizer Inc. - Overview
Exhibits158: Pfizer Inc. - Product / Service
Exhibits159: Pfizer Inc. - Key news
Exhibits160: Pfizer Inc. - Key offerings
Exhibits161: Sanofi SA - Overview
Exhibits162: Sanofi SA - Business segments
Exhibits163: Sanofi SA - Key news
Exhibits164: Sanofi SA - Key offerings
Exhibits165: Sanofi SA - Segment focus
Exhibits166: The OTClab B.V. - Overview
Exhibits167: The OTClab B.V. - Product / Service
Exhibits168: The OTClab B.V. - Key offerings
Exhibits169: Inclusions checklist
Exhibits170: Exclusions checklist
Exhibits171: Currency conversion rates for US$
Exhibits172: Research methodology
Exhibits173: Information sources
Exhibits174: Data validation
Exhibits175: Validation techniques employed for market sizing
Exhibits176: Data synthesis
Exhibits177: 360 degree market analysis
Exhibits178: List of abbreviations

Product Code: IRTNTR75557

The onychomycosis treatment market is forecasted to grow by USD 1772 mn during 2023-2028, accelerating at a CAGR of 7.03% during the forecast period. The report on the onychomycosis treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of onychomycosis, increasing awareness of onychomycosis treatment, and growing aging population.

Technavio's onychomycosis treatment market is segmented as below:

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	6.57%
CAGR	7.03%
Incremental Value	$1772 mn

By Type

Pharmacological
Non-pharmacological

By Distribution Channel

Offline
Online

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing demand for topical treatment for onychomycosis as one of the prime reasons driving the onychomycosis treatment market growth during the next few years. Also, advancements in technology in onychomycosis treatment and increasing adoption of combination therapies for treatment of onychomycosis will lead to sizable demand in the market.

The report on the onychomycosis treatment market covers the following areas:

Onychomycosis treatment market sizing
Onychomycosis treatment market forecast
Onychomycosis treatment market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading onychomycosis treatment market vendors that include Alembic Pharmaceuticals Ltd., Almirall SA, Astellas Pharma Inc., Bausch Health Companies Inc., Bayer AG, Cipla Inc., Dr Reddys Laboratories Ltd., Fotona d.o.o, Galderma SA, GlaxoSmithKline Plc, Kaken Pharmaceutical Co. Ltd., Lupin Ltd., Medimetriks Pharmaceuticals Inc., Moberg Pharma AB, Novartis AG, Perrigo Co. Plc, Pfizer Inc., Sanofi SA, Teva Pharmaceutical Industries Ltd., and The OTClab B.V.. Also, the onychomycosis treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
2.2 Market characteristics
- Market characteristics analysis
2.3 Value chain analysis
- Value Chain Analysis

3 Market Sizing

3.1 Market definition
- Offerings of companies included in the market definition
3.2 Market segment analysis
- Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global Onychomycosis Treatment Market 2018 - 2022
- Historic Market Size - Data Table on Global Onychomycosis Treatment Market 2018 - 2022 ($ million)
4.2 Type segment analysis 2018 - 2022
- Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.3 Distribution Channel segment analysis 2018 - 2022
- Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

6.1 Market segments
- Chart on Type - Market share 2023-2028 (%)
- Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
6.3 Pharmacological - Market size and forecast 2023-2028
- Chart on Pharmacological - Market size and forecast 2023-2028 ($ million)
- Data Table on Pharmacological - Market size and forecast 2023-2028 ($ million)
- Chart on Pharmacological - Year-over-year growth 2023-2028 (%)
- Data Table on Pharmacological - Year-over-year growth 2023-2028 (%)
6.4 Non-pharmacological - Market size and forecast 2023-2028
- Chart on Non-pharmacological - Market size and forecast 2023-2028 ($ million)
- Data Table on Non-pharmacological - Market size and forecast 2023-2028 ($ million)
- Chart on Non-pharmacological - Year-over-year growth 2023-2028 (%)
- Data Table on Non-pharmacological - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by Distribution Channel

7.1 Market segments
- Chart on Distribution Channel - Market share 2023-2028 (%)
- Data Table on Distribution Channel - Market share 2023-2028 (%)
7.2 Comparison by Distribution Channel
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
7.3 Offline - Market size and forecast 2023-2028
- Chart on Offline - Market size and forecast 2023-2028 ($ million)
- Data Table on Offline - Market size and forecast 2023-2028 ($ million)
- Chart on Offline - Year-over-year growth 2023-2028 (%)
- Data Table on Offline - Year-over-year growth 2023-2028 (%)
7.4 Online - Market size and forecast 2023-2028
- Chart on Online - Market size and forecast 2023-2028 ($ million)
- Data Table on Online - Market size and forecast 2023-2028 ($ million)
- Chart on Online - Year-over-year growth 2023-2028 (%)
- Data Table on Online - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Distribution Channel
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
- Chart on Japan - Market size and forecast 2023-2028 ($ million)
- Data Table on Japan - Market size and forecast 2023-2028 ($ million)
- Chart on Japan - Year-over-year growth 2023-2028 (%)
- Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints

11 Competitive Landscape

11.1 Overview
11.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
- Overview on factors of disruption
11.4 Industry risks
- Impact of key risks on business

12 Competitive Analysis

12.1 Companies profiled
- Companies covered
12.2 Market positioning of companies
- Matrix on companies position and classification
12.3 Almirall SA
- Almirall SA - Overview
- Almirall SA - Product / Service
- Almirall SA - Key news
- Almirall SA - Key offerings
12.4 Astellas Pharma Inc.
- Astellas Pharma Inc. - Overview
- Astellas Pharma Inc. - Product / Service
- Astellas Pharma Inc. - Key news
- Astellas Pharma Inc. - Key offerings
12.5 Bausch Health Companies Inc.
- Bausch Health Companies Inc. - Overview
- Bausch Health Companies Inc. - Business segments
- Bausch Health Companies Inc. - Key news
- Bausch Health Companies Inc. - Key offerings
- Bausch Health Companies Inc. - Segment focus
12.6 Bayer AG
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
12.7 Cipla Inc.
- Cipla Inc. - Overview
- Cipla Inc. - Business segments
- Cipla Inc. - Key news
- Cipla Inc. - Key offerings
- Cipla Inc. - Segment focus
12.8 Fotona d.o.o
- Fotona d.o.o - Overview
- Fotona d.o.o - Product / Service
- Fotona d.o.o - Key offerings
12.9 Galderma SA
- Galderma SA - Overview
- Galderma SA - Product / Service
- Galderma SA - Key offerings
12.10 GlaxoSmithKline Plc
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
12.11 Kaken Pharmaceutical Co. Ltd.
- Kaken Pharmaceutical Co. Ltd. - Overview
- Kaken Pharmaceutical Co. Ltd. - Product / Service
- Kaken Pharmaceutical Co. Ltd. - Key offerings
12.12 Medimetriks Pharmaceuticals Inc.
- Medimetriks Pharmaceuticals Inc. - Overview
- Medimetriks Pharmaceuticals Inc. - Product / Service
- Medimetriks Pharmaceuticals Inc. - Key offerings
12.13 Moberg Pharma AB
- Moberg Pharma AB - Overview
- Moberg Pharma AB - Product / Service
- Moberg Pharma AB - Key offerings
12.14 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
12.15 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
12.16 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
12.17 The OTClab B.V.
- The OTClab B.V. - Overview
- The OTClab B.V. - Product / Service
- The OTClab B.V. - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
13.3 Currency conversion rates for US$
- Currency conversion rates for US$
13.4 Research methodology
- Research methodology
13.5 Data procurement
- Information sources
13.6 Data validation
- Data validation
13.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
13.8 Data synthesis
- Data synthesis
13.9 360 degree market analysis
- 360 degree market analysis
13.10 List of abbreviations
- List of abbreviations

爪真菌症治療の世界市場、2024年～2028年

Global Onychomycosis Treatment Market 2024-2028

目次

第1章エグゼクティブサマリー

第2章市場情勢

第3章市場規模の評価

第4章市場規模実績

第5章ファイブフォース分析

第6章市場セグメンテーション：タイプ別

第7章市場セグメンテーション：流通チャネル別

第8章顧客情勢

第9章地域別情勢

第10章促進要因・課題・機会・抑制要因

第11章競合情勢

第12章競合分析

第13章付録

Table of Contents

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Historic Market Size

5 Five Forces Analysis

6 Market Segmentation by Type

7 Market Segmentation by Distribution Channel

8 Customer Landscape

9 Geographic Landscape

10 Drivers, Challenges, and Opportunity/Restraints

11 Competitive Landscape

12 Competitive Analysis

13 Appendix

爪真菌症治療の世界市場、2024年～2028年

Global Onychomycosis Treatment Market 2024-2028

目次

第1章 エグゼクティブサマリー

第2章 市場情勢

第3章 市場規模の評価

第4章 市場規模実績

第5章 ファイブフォース分析

第6章 市場セグメンテーション：タイプ別

第7章 市場セグメンテーション：流通チャネル別

第8章 顧客情勢

第9章 地域別情勢

第10章 促進要因・課題・機会・抑制要因

第11章 競合情勢

第12章 競合分析

第13章 付録

Table of Contents

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Historic Market Size

5 Five Forces Analysis

6 Market Segmentation by Type

7 Market Segmentation by Distribution Channel

8 Customer Landscape

9 Geographic Landscape

10 Drivers, Challenges, and Opportunity/Restraints

11 Competitive Landscape

12 Competitive Analysis

13 Appendix

第1章エグゼクティブサマリー

第2章市場情勢

第3章市場規模の評価

第4章市場規模実績

第5章ファイブフォース分析

第6章市場セグメンテーション：タイプ別

第7章市場セグメンテーション：流通チャネル別

第8章顧客情勢

第9章地域別情勢

第10章促進要因・課題・機会・抑制要因

第11章競合情勢

第12章競合分析

第13章付録